DERIVATIVES SHOWING PPAR-RECEPTOR AGONIST ACTIVITY Russian patent published in 2011 - IPC C07D277/82 C07D211/22 C07D211/58 C07D241/04 C07D241/44 C07D401/04 C07D403/04 C07D413/14 C07D417/04 C07D417/12 C07D417/14 A61K31/4439 A61K31/445 A61K31/454 A61K31/496 A61K31/498 A61K31/551 A61P3/06 A61P3/10 A61P9/10 

Abstract RU 2415846 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: compound of formula pharmaceutically acceptable salt or solvate of a compound or salt (I), ring Q represents optionally substituted monocyclic or condensed (C6-C12)aryl or optionally substituted monocyclic or condensed heteroaryl where said substitutes are chosen from: halogen; (C1-C6)alkyl optionally substituted by 1-3 halogen atoms; (C1-C6)alkylsulphonyl; phenyl optionally substituted by 1 or 2 substitutes chosen from halogen, (C1-C6)alkyl which can be substituted by 1-3 halogen atoms, groups (C1-C6)alkylamino, di(C1-C6)alkylamino, (C1-C6)alkoxy, (C1-C6)alkoxy(C1-C6)alkyl and (C1-C6)alkylthio; monocyclic or condensed heteroaryl optionally substituted by halogen; or oxo; Y1 represents a bond or -NR6-CO-, where R6 represents hydrogen, ring A represents optionally substituted a nonaromatic heterocyclyldiyl where said substitutes are chosen from (C1-C6)alkyl optionally substituted by groups hydroxy, (C1-C6)alkylamino, di(C1-C6)alkylamino, morpholino, (C1-C6)alkylaminocarbonyl, di(C1-C6)alkylaminocarbonyl; cyano; (C3-C6)cycloalkyl; (C1-C6)alkoxy; (C1-C6)alkoxy(C1-C6)alkyl; phenyl; benzyl; benzyloxymethyl; thienyl; 4-8-members monocyclic nonaromatic heterocycle having 1 or 2 heteroatoms chosen from N or O, and optionally substituted by 1 or 2 substitutes chosen from (C1-C6)alkyl, (C1-C6)alkoxy, (C1-C6)alkoxy(C1-C6)alkyl and oxo; (C1-C6)alkylamino; di(C1-C6)alkylamino; a group of formula: -Y2Z'- represents a group of formula: [Formula 2] each R7 independently represents hydrogen, (C1-C6)alkyl or (C3-C6)cycloalkyl, each of R8 and R9 independently represents hydrogen or (C1-C6)alkyl, n is equal to an integer 0 to 3, Z1 represents a bond, -O-, -S- or-NR9 - where R9 represents hydrogen, (C1-C6)alkyl, acyl or (C1-C6)alkylsulphonyl, ring B represents optionally substituted aromatic carbocyclediyl or optionally substituted aromatic heterocyclediyl where said substitutes are chosen from (C1-C6)alkyl, halogen, (C1-C6)alkoxy and oxo; Y3 represents a bond optionally substituted (C1-C6)alkylene or (C3-C6)cycloalylene, optionally interrupted -O- or optionally substituted (C2-C6)alkenylene where said substitutes are chosen from (C1-C6)alkyl, (C3-C6)cycloalkyl, halogen and (C1-C6)alkoxycarbonyl; Z2 represents COOR3; R3 represents hydrogen or (C1-C6)alkyl.

EFFECT: preparation of new compounds.

30 cl, 9 tbl, 944 ex

Similar patents RU2415846C2

Title Year Author Number
DERIVATIVES OF AMIDE, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT 2000
  • Braun Dirg Saterlend
RU2284187C2
COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS 2009
  • Ueta Kiitiro
  • Arakava Kendzi
  • Matsusita Jasuaki
RU2481106C2
NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES 2017
  • Khyubsh, Valter
  • Kebberling, Jokhannes
  • Keler, Adeline
  • Shvarts, Khans-Georg
  • Kulke, Daniel
  • Velts, Klaudia
  • Ilg, Tomas
  • Berngen, Kirsten
  • Chzhuang, Vej
  • Gribenov, Nils
  • Bem, Klaudia
  • Lindner, Nils
  • Khink, Majke
  • Gergens, Ulrikh
RU2772283C2
PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS 2005
  • Dajkson Dzhuli A.
  • Brennen Kehtrin
  • Majrehnda Karl
  • Chehndler Brent
  • Fillips Barton
  • Fan Dzhianmej
  • Brehnds Majkl
  • Makkljur Andrea
  • Dzhouns Bendzhamin
  • Fu Venlang
  • Birer Donald
  • Mehgnuson Stiven
  • Kljunder Khehrold K. Eh.
RU2401269C2
NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS 2019
  • Liu, Hong
  • Li, Jia
  • Wang, Jiang
  • Zang, Yi
  • Li, Jian
  • Li, Jingya
  • Sun, Dandan
  • Jiang, Hualiang
  • Chen, Kaixian
RU2768828C1
THIOLSULFONAMIDE INHIBITORS OF METALLOPROTEASE 1997
  • Dekreshentso Gehri
  • Abbas Zakhir S.
  • Freskos Dzhon N.
  • Getman Dehniel P.
  • Khajntts Robert M.
  • Mishke Brent V.
  • Makdonal'D Dzhozef Dzh.
RU2202540C2
PYRIDINE COMPOUNDS CONTAINING SEVEN ATOMS IN RING, METHOD OF THEIR OBTAINING, PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION 2017
  • Den Syanmin
  • Chzhou, Davan
  • Chen Lanfen
  • Khe Chzhisyan
  • Fan Futsin
RU2748696C2
DERIVATIVES OF QUINOLINE, METHOD FOR THEIR PREPARING AND THEIR USING, MEDICINAL AGENT AND METHOD FOR INHIBITION OF TUMOR CELL PROLIFERATION 2001
  • Gjunter Ehkkhard
  • Kucher Berngard
  • Nikel' Bernd
  • Shmidt Jurgen
  • Ehmig Peter
RU2265602C2
USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS 2010
  • Bergmann John E.
  • Cutshall Neil S.
  • Demopulos Gregory A.
  • Florio Vincent A.
  • Gaitanaris George
  • Gray Patrick
  • Hohmann John
  • Onrust Rene
  • Zeng Hongkui
RU2600869C2
MONOMER DERIVATIVES OF GLYCOPEPTIDE ANTIBIOTIC 2005
  • Arimoto Khirokazu
  • Lu Tszjun'
  • Jamano Josinori
  • Jasukata Tatsuro
  • Josida Osamu
  • Ivaki Tsutomu
  • Josida Jutaka
  • Kato Issei
  • Morimoto Kendzi
  • Jasosima Kajo
RU2424248C2

RU 2 415 846 C2

Authors

Itai Akiko

Muto Suzumu

Tokujama R'Juko

Fukusava Khiroshi

Okhara Takafumi

Kato Terukazu

Takajama Khirotsugu

Dates

2011-04-10Published

2006-08-24Filed